B60.1 - Malignant malaria
ICD-10 B60.1 is a billable code used to indicate a diagnosis of b60.1 - malignant malaria.
Malignant malaria, primarily caused by Plasmodium falciparum, is a severe form of malaria characterized by high parasitemia and significant morbidity and mortality. This protozoal infection is transmitted through the bite of infected Anopheles mosquitoes and is endemic in tropical and subtropical regions. Patients typically present with symptoms such as high fever, chills, sweating, headache, nausea, vomiting, and abdominal pain. Severe cases may lead to complications like cerebral malaria, acute respiratory distress syndrome (ARDS), and multi-organ failure. Diagnosis is confirmed through blood smears or rapid diagnostic tests that detect malaria antigens. Treatment involves the use of antimalarial medications, with artemisinin-based combination therapies (ACTs) being the first-line treatment. In severe cases, intravenous administration of quinine or artesunate may be necessary. Prompt diagnosis and treatment are crucial to reduce the risk of complications and improve patient outcomes.
Detailed clinical notes on symptoms, lab results, and treatment plans.
Patients presenting with fever and travel history to endemic regions.
Ensure documentation reflects the severity and any complications of malaria.
Immediate assessment notes, lab results, and treatment administered.
Patients with acute febrile illness and suspected malaria.
Timely documentation is critical for accurate coding and treatment.
Used for rapid diagnosis of malaria in patients presenting with fever.
Document the reason for the test and results.
Infectious disease specialists should ensure accurate interpretation of test results.
Malignant malaria is primarily caused by the protozoan parasite Plasmodium falciparum, which is known for its severe clinical manifestations.
